Maluccio, M. & Covey, A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J. Clin. 62, 394–399 (2012).
Kanda, M. et al. Extrahepatic metastasis of hepatocellular carcinoma: Incidence and risk factors. Liver Int. 28, 1256–1263 (2008).
Lin, S. C., Shih, S. C., Kao, C. R. & Chou, S. Y. Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World J. Gastroenterol. 9, 1208–1211 (2003).
Katyal, S. et al. Extrahepatic metastases of hepatocellular carcinoma. Radiology 216, 698–703 (2000).
Abbas, A. et al. Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig. Dis. Sci. 59, 2813–2820 (2014).
Forner, A., Reig, M. & Bruix, J. Hepatocellular carcinoma. Lancet 391, 1301–1314 (2018).
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7–30 (2018).
El-Serag, H. B. Hepatocellular carcinoma. N. Engl. J. Med. 365, 1118–1127 (2011).
Onofrei, C., Patel, D. & Noor, A. An unexpected source of hemoptysis. Chest 150, 682a–682a (2016).
Kawaguchi, T. et al. Successful treatment for bronchial bleeding from invasive pulmonary metastasis of hepatocellular carcinoma: A case report. Hepatogastroenterology 48, 851–853 (2001).
Fartoukh, M. et al. Early prediction of in-hospital mortality of patients with hemoptysis: An approach to defining severe hemoptysis. Respiration 83, 106–114 (2012).
Hayakawa, K. et al. Bronchial artery embolization for hemoptysis: Immediate and long-term results. Cardiovasc. Intervent. Radiol. 15, 154–158 (1992) (discussion 158–159).
Knott-Craig, C. J. et al. Management and prognosis of massive hemoptysis. Recent experience with 120 patients. J. Thorac. Cardiovasc. Surg. 105, 394–397 (1993).
Fernando, H. C., Stein, M., Benfield, J. R. & Link, D. P. Role of bronchial artery embolization in the management of hemoptysis. Arch. Surg. 133, 862–866 (1998).
Mal, H. et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 115, 996–1001 (1999).
Panda, A., Bhalla, A. S. & Goyal, A. Bronchial artery embolization in hemoptysis: A systematic review. Diagn. Interv. Radiol. 23, 307–317 (2017).
Xu, S., Guan, L. J., Shi, B. Q., Tan, Y. S. & Zhang, X. J. Recurrent hemoptysis after bronchial artery embolization: Prediction using a nomogram and artificial neural network model. AJR Am. J. Roentgenol. 215, 1490–1498 (2020).
Shin, B. S., Jeon, G. S., Lee, S. A. & Park, M. H. Bronchial artery embolisation for the management of haemoptysis in patients with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 15, 1093–1098 (2011).
Martin, L. N., Higgins, L., Mohabir, P., Sze, D. Y. & Hofmann, L. V. Bronchial artery embolization for hemoptysis in cystic fibrosis patients: A 17-year review. J. Vasc. Interv. Radiol. 31, 331–335 (2020).
Shin, B. et al. Outcomes of bronchial artery embolization for life-threatening hemoptysis in patients with chronic pulmonary Aspergillosis. PLoS ONE 11, e0168373 (2016).
Takeda, K. et al. Long-term outcomes of bronchial artery embolization for patients with non-mycobacterial non-fungal infection bronchiectasis. Respiration 99, 961–969 (2020).
Mehta, A. S. et al. Bronchial artery embolization for malignant hemoptysis: A single institutional experience. J. Thorac. Dis. 7, 1406–1413 (2015).
Han, K., Yoon, K. W., Kim, J. H. & Kim, G. M. Bronchial artery embolization for hemoptysis in primary lung cancer: A retrospective review of 84 patients. J. Vasc. Interv. Radiol. 30, 428–434 (2019).
Wang, G. R., Ensor, J. E., Gupta, S., Hicks, M. E. & Tam, A. L. Bronchial artery embolization for the management of hemoptysis in oncology patients: Utility and prognostic factors. J. Vasc. Interv. Radiol. 20, 722–729 (2009).
Garcia-Olive, I. et al. Results of bronchial artery embolization for the treatment of hemoptysis caused by neoplasm. J. Vasc. Interv. Radiol. 25, 221–228 (2014).
Witt, C. et al. Value of bronchial artery embolisation with platinum coils in tumorous pulmonary bleeding. Eur. J. Cancer 36, 1949–1954 (2000).
Park, H. S. et al. Bronchial artery and systemic artery embolization in the management of primary lung cancer patients with hemoptysis. Cardiovasc. Interv. Radiol. 30, 638–643 (2007).
Angle, J. F. et al. Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J. Vasc. Interv. Radiol. 21, 1479–1486 (2010).
Chun, J. Y. et al. Radiological management of hemoptysis: A comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc. Interv. Radiol. 33, 240–250 (2010).
Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228–247 (2009).
Boas, F. E. et al. Bronchial or pulmonary artery chemoembolization for unresectable and unablatable lung metastases: A phase I clinical trial. Radiology 301, 474–484 (2021).
Georgiades, C. Chemoembolization for lung neoplasms: Exuberant expectations versus meticulous investigation. Radiology 301, 485–486 (2021).
Hori, A. et al. Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma. Br. J. Radiol. 93, 20190407 (2020).
Park, C. et al. Clinical significance of the initial and best responses after chemoembolization in the treatment of intermediate-stage hepatocellular carcinoma with preserved liver function. J. Vasc. Interv. Radiol. 31, 1998e1991-2006e1991 (2020).
Brown, K. T. et al. Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. J. Clin. Oncol. 34, 2046–2053 (2016).
Roth, G. S. et al. Comparison of trans-arterial chemoembolization and bland embolization for the treatment of hepatocellular carcinoma: A propensity score analysis. Cancers (Basel) 13, 812 (2021).
Kishore, S. A., Bajwa, R. & Madoff, D. C. Embolotherapeutic strategies for hepatocellular carcinoma: 2020 update. Cancers (Basel) 12, 791 (2020).
